Fast, Simple, and Accurate PCR Testing for Primary Care

Cepheid, a leader in molecular diagnostics, offers solutions that increase primary care efficiency while achieving better clinical care.

GeneXpert® Family of Systems Deliver Unmatched Results from Decentralized Testing to the Point of Care

Point-of-care providers are at the frontline, working tirelessly in primary care, urgent care, and pediatric settings to deliver the highest standard of care to their patients, every day. Providers need accurate, onsite testing to properly diagnose and treat patients in one visit. Cepheid offers fast, accurate, and easy PCR results – the gold-standard solution for hospitals, laboratories, and near patient settings. Explore the GeneXpert® system and the GeneXpert® Xpress system, as well as our broad test menu, to take your team to the next level.

GX Systems Test Menu

Seamless In-office Testing

  • Reduced footprint with barcode scanners and touchscreen available on GeneXpert® Xpress
  • Simple workflow with minimal hands-on time and walk away capabilities for unparalleled efficiency
  • No specialized training and reduced daily maintenance required
  • Compact and scalable design options to grow with your testing needs
  • On-demand and random access with mix-and-match test capabilities for optimal flexibility
  • Closed cartridge technology reduces the risk of contamination and enables random-access

Testing as simple as 1, 2, 3

Respiratory Solutions

Build your Primary Care with a Single Solution
 for Respiratory Care

Test with the confidence of PCR using Cepheid’s GeneXpert® System and Xpress® tests. Standardized CLIA waived molecular testing for any primary care setting — from health systems to standalone physician offices and specialty clinics. Achieve accurate, actionable results when and where they are needed the most.

Xpert® Xpress Strep A

Xpert® Xpress Strep A

Qualitative real-time PCR test providing accurate detection of Group A Streptococcus in as soon as 18 minutes*
Xpert® Xpress CoV-2 plus

Xpert® Xpress CoV-2 plus

Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2.
Xpert® Xpress CoV-2/Flu/RSV plus

Xpert® Xpress CoV-2/Flu/RSV plus

Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses.
Xpert® Xpress Flu

Xpert® Xpress Flu

Accurate and reliable detection of Flu A and Flu B in as soon as 20 minutes

Women’s and Sexual Health Solutions

Build Your Primary Care Practice with a Single Solution for Women's and Sexual Health Testing

Primary Care is at the forefront of the fight. Studies have found that primary care clinics might diagnose up to half of the reported STDs.+ Achieve accurate, actionable results when and where they are needed the most.

Xpert® TV

Xpert® TV

Fast and Accurate Diagnosis of Trichomoniasis in 90 minutes or less
Xpert® CT/NG

Xpert® CT/NG

90-minute detection and differentation of Chlymdia trachomatis (CT) and Neisseria Gonorrhoea (NG)
Xpert® GBS

Xpert® GBS

Intrapartum screening for Group B Streptococcus during labor/delivery in less than 1 hour
Xpert® Xpress MVP

Xpert® Xpress MVP

Multiplex vaginal panel that enables results within 60 minutes from a single specimen for Bacterial Vaginosis, Vulvovaginal Candidiasis, and Trichomoniasis

- For use in a CLIA-certified facility 

Educational Materials

Respiratory Testing Brochure (Point of Care)

Sexual Health Testing Brochure (Point of Care)

White Paper: Leveraging Point-of-Care PCR Testing in Primary Care 

Select your area of interest

US-IVD. In Vitro Diagnostic Medical Device

Please see individual product inserts for full test run times and early assay termination times.

Please see Product inserts for individual test clearances.

*These tests have not been FDA cleared or approved. These tests have been authorized for emergency use by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2 plus has been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

^Full test runtime is 36 minutes. SARS-CoV-2 positive results available in as soon as 25 minutes with early assay termination.

+Brackbill RM, Sternberg MR, Fishbein M. Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect 1999;31:10–5. Cross Refexternal icon Pub Medexternal icon